About Exenatide
            
            Class: | GLP-1 receptor agonist  
Use: | Treatment of type 2 diabetes mellitus to improve glycemic control in conjunction with diet and exercise  
Adult dose: | Initial dose: 5 mcg subcutaneously twice daily; may increase to 10 mcg subcutaneously twice daily after 1 month based on tolerance and efficacy  
Pediatric dose: | Safety and efficacy not established in pediatric patients  
Side effects: | Nausea, vomiting, diarrhea, constipation, headache, hypoglycemia (especially when used with sulfony
         
        
            
                
                
                    
                        Drug Class
                    
                    GLP-1 receptor agonist
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of type 2 diabetes mellitus to improve glycemic control in conjunction with diet and exercise
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator (36°F to 46°F or 2°C to 8°C); may be kept at room temperature (up to 77°F or 25°C) for up to 30 days after first use
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Lilly Pharma Fertigung Und Distribution GmbH & CO., GERMANY
                    
                    
                    Package Size
                    60 Dose Pre-filled Pen
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 377.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose: 5 mcg subcutaneously twice daily; may increase to 10 mcg subcutaneously twice daily after 1 month based on tolerance and efficacy
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Nausea, vomiting, diarrhea, constipation, headache, hypoglycemia (especially when used with sulfonylureas), injection site reactions
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, severe gastrointestinal disease, hypersensitivity to exenatide or any component of the formulation
         
        
        
            
                Important Warnings
            
            Risk of pancreatitis; monitor for signs and symptoms; not recommended for use in patients with severe renal impairment; potential risk of thyroid tumors; caution in patients with a history of pancreatitis or gallbladder disease
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.